Save your place

Sign in to WhoBought

Please try again later.

Day One Biopharmaceuticals, Inc. (DAWN) institutional ownership

Market cap$674M SectorHealthcare
Funds holding · Q1 2026
240
reported DAWN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
136 buyers · 104 sellers

Day One Biopharmaceuticals, Inc. (DAWN) price and institutional activity

Dates

Q1 2026

$0 bought by 136 investors
Glazer Capital, LLCFil Ltd +134 more
$0 sold by 104 investors
Atlas Venture Life Science Advisors, LLCFMR LLC +102 more
Bought Sold Totals per quarter; hover a bar for the names.

Day One Biopharmaceuticals, Inc. (DAWN) institutional activity · 240

Investor Type Est. change Change Δ Own Date
Atlas Venture Life Science Advisors, LLC · Exited
Change −6.4M Δ Own −100.0% Date Q1 2026
Atlas Venture Life Science Advisors, LLC Exited· Q1 2026 −6.4M −100.0% Q1 2026
FMR LLC · Reduced
Change −5.7M Δ Own −99.6% Date Q1 2026
FMR LLC Reduced· Q1 2026 −5.7M −99.6% Q1 2026
Vestal Point Capital, LP · Exited
Change −5.2M Δ Own −100.0% Date Q1 2026
Vestal Point Capital, LP Exited· Q1 2026 −5.2M −100.0% Q1 2026
Glazer Capital, LLC · New
Change +4.7M Date Q1 2026
Glazer Capital, LLC New· Q1 2026 +4.7M Q1 2026
Fil Ltd · New
Change +4.1M Date Q1 2026
Fil Ltd New· Q1 2026 +4.1M Q1 2026
Kryger Capital LLC · New
Change +3.9M Date Q1 2026
Kryger Capital LLC New· Q1 2026 +3.9M Q1 2026
JPMorgan Chase & Co · Added
Change +3.1M Date Q1 2026
JPMorgan Chase & Co Added· Q1 2026 +3.1M Q1 2026
Pictet Asset Management Holding SA · Reduced
Change −3.0M Date Q1 2026
Pictet Asset Management Holding SA Reduced· Q1 2026 −3.0M Q1 2026
AQR Arbitrage LLC · New
Change +2.5M Date Q1 2026
AQR Arbitrage LLC New· Q1 2026 +2.5M Q1 2026
UBS Group AG · Added
Change +2.1M Date Q1 2026
UBS Group AG Added· Q1 2026 +2.1M Q1 2026
Aigh Capital Management LLC · Exited
Change −2.0M Δ Own −100.0% Date Q1 2026
Aigh Capital Management LLC Exited· Q1 2026 −2.0M −100.0% Q1 2026
O'Connor Alternative Investments LLC · New
Change +1.9M Date Q1 2026
O'Connor Alternative Investments LLC New· Q1 2026 +1.9M Q1 2026
BlackRock · Reduced
Change −1.8M Date Q1 2026
BlackRock Reduced· Q1 2026 −1.8M Q1 2026
Perceptive Advisors LLC · New
Change +1.8M Date Q1 2026
Perceptive Advisors LLC New· Q1 2026 +1.8M Q1 2026
Oddo Bhf Asset Management Sas · New
Change +1.6M Date Q1 2026
Oddo Bhf Asset Management Sas New· Q1 2026 +1.6M Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 240

Famous investor activity in Day One Biopharmaceuticals, Inc. (DAWN)

Day One Biopharmaceuticals, Inc. (DAWN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ai Day1 LLC · 10% Owner Other Form 4 events -$278M
Price $21.50 Qty -12.9M Owned 0 Trade date Apr 23, 2026 Filed date Apr 27, 2026
Ai Day1 LLC 10% Owner Other Form 4 events $21.50 -12.9M -$278M 0 Apr 23, 2026 Apr 27, 2026
Ai Day1 LLC · 10% Owner Shares transferred outside the market (D), often for tax or as a gift, not a market sale -$18M
Price $21.50 Qty -828K Owned 0 Trade date Apr 23, 2026 Filed date Apr 27, 2026
Ai Day1 LLC 10% Owner Shares transferred outside the market (D), often for tax or as a gift, not a market sale $21.50 -828K -$18M 0 Apr 23, 2026 Apr 27, 2026
Bender Jeremy · Director 17 operations -5.3M
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Bender Jeremy Director 17 operations -5.3M 0 Apr 23, 2026 Apr 23, 2026
Vasconcelles Michael · Officer 5 operations -854K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Vasconcelles Michael Officer 5 operations -854K 0 Apr 23, 2026 Apr 23, 2026
York Charles N. II · Officer 11 operations -1.8M
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
York Charles N. II Officer 11 operations -1.8M 0 Apr 23, 2026 Apr 23, 2026
Dubow Adam · Officer 11 operations -903K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Dubow Adam Officer 11 operations -903K 0 Apr 23, 2026 Apr 23, 2026
Holles Natalie C. · Director 8 operations -274K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Holles Natalie C. Director 8 operations -274K 0 Apr 23, 2026 Apr 23, 2026
Ramasastry Saira · Director 8 operations -264K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Ramasastry Saira Director 8 operations -264K 0 Apr 23, 2026 Apr 23, 2026
Josey John A. · Director 8 operations -273K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Josey John A. Director 8 operations -273K 0 Apr 23, 2026 Apr 23, 2026
Garland J. Scott · Director 6 operations -184K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Garland J. Scott Director 6 operations -184K 0 Apr 23, 2026 Apr 23, 2026
Dable Habib J. · Director 4 operations -136K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Dable Habib J. Director 4 operations -136K 0 Apr 23, 2026 Apr 23, 2026
Grossman William · Director 4 operations -136K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Grossman William Director 4 operations -136K 0 Apr 23, 2026 Apr 23, 2026
Nicholson Garry A. · Director 5 operations -141K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Nicholson Garry A. Director 5 operations -141K 0 Apr 23, 2026 Apr 23, 2026
Merendino Lauren · Officer 9 operations -835K
Owned 0 Trade date Apr 23, 2026 Filed date Apr 23, 2026
Merendino Lauren Officer 9 operations -835K 0 Apr 23, 2026 Apr 23, 2026
Merendino Lauren · Officer Sell −$67K
Price $11.60 Qty −6K Owned 60K Trade date Feb 17, 2026 Filed date Feb 18, 2026
Merendino Lauren Officer Sell $11.60 −6K −$67K 60K Feb 17, 2026 Feb 18, 2026
15 of 42
15 of 42 Sign in to continue to older insider transactions.

Day One Biopharmaceuticals, Inc. (DAWN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Ai Day1 LLC 12.9M
% of shares outstanding 13.2% Filing date Aug 5, 2024
Ai Day1 LLC 12.9M 13.2% Aug 5, 2024
FMR LLC 11.3M
% of shares outstanding 11.2% Filing date Nov 7, 2024
FMR LLC 11.3M 11.2% Nov 7, 2024
Ra Capital Management, L.P. 7.8M
% of shares outstanding 9.0% Filing date Feb 14, 2024
Ra Capital Management, L.P. 7.8M 9.0% Feb 14, 2024
BlackRock Inc. 5.1M
% of shares outstanding 5.9% Filing date Jan 29, 2024
BlackRock Inc. 5.1M 5.9% Jan 29, 2024
Atlas Venture Fund Xi, L.P. 4.8M
% of shares outstanding 5.5% Filing date Nov 14, 2024
Atlas Venture Fund Xi, L.P. 4.8M 5.5% Nov 14, 2024
Vanguard Group Inc 4.8M
% of shares outstanding 5.5% Filing date Feb 13, 2024
Vanguard Group Inc 4.8M 5.5% Feb 13, 2024
Canaan Xi L.P. 2.5M
% of shares outstanding 3.5% Filing date Nov 2, 2022
Canaan Xi L.P. 2.5M 3.5% Nov 2, 2022
Vestal Point Capital, LP 0
% of shares outstanding 0.0% Filing date May 15, 2026
Vestal Point Capital, LP 0 0.0% May 15, 2026
8 of 11

Day One Biopharmaceuticals, Inc. (DAWN) ownership FAQ

Who owns DAWN?

240 reporting institutions disclosed DAWN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.